NO302570B1 - Substituerte pipekolinsyrederivater som HIV-protease-inhibitorer, farmasöytiske blandinger inneholdende dem og anvendelser av derivatene - Google Patents

Substituerte pipekolinsyrederivater som HIV-protease-inhibitorer, farmasöytiske blandinger inneholdende dem og anvendelser av derivatene

Info

Publication number
NO302570B1
NO302570B1 NO943383A NO943383A NO302570B1 NO 302570 B1 NO302570 B1 NO 302570B1 NO 943383 A NO943383 A NO 943383A NO 943383 A NO943383 A NO 943383A NO 302570 B1 NO302570 B1 NO 302570B1
Authority
NO
Norway
Prior art keywords
derivatives
pharmaceutical compositions
compositions containing
protease inhibitors
hiv protease
Prior art date
Application number
NO943383A
Other languages
English (en)
Norwegian (no)
Other versions
NO943383L (no
NO943383D0 (no
Inventor
Paul Cates Anderson
Francois Soucy
Christiane Yoakim
Pierre Lavallee
Pierre Louis Beaulieu
Original Assignee
Boehringer Ingelheim Ca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ca Ltd filed Critical Boehringer Ingelheim Ca Ltd
Publication of NO943383L publication Critical patent/NO943383L/no
Publication of NO943383D0 publication Critical patent/NO943383D0/no
Publication of NO302570B1 publication Critical patent/NO302570B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
NO943383A 1992-03-13 1994-09-12 Substituerte pipekolinsyrederivater som HIV-protease-inhibitorer, farmasöytiske blandinger inneholdende dem og anvendelser av derivatene NO302570B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85071692A 1992-03-13 1992-03-13
PCT/CA1993/000096 WO1993018003A1 (en) 1992-03-13 1993-03-12 Substitued pipecolinic acid derivatives as hiv protease inhibitors

Publications (3)

Publication Number Publication Date
NO943383L NO943383L (no) 1994-09-12
NO943383D0 NO943383D0 (no) 1994-09-12
NO302570B1 true NO302570B1 (no) 1998-03-23

Family

ID=25308925

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943383A NO302570B1 (no) 1992-03-13 1994-09-12 Substituerte pipekolinsyrederivater som HIV-protease-inhibitorer, farmasöytiske blandinger inneholdende dem og anvendelser av derivatene

Country Status (25)

Country Link
US (1) US5807870A (es)
EP (1) EP0560268B1 (es)
JP (1) JP3258422B2 (es)
KR (1) KR950700253A (es)
AP (1) AP393A (es)
AT (1) ATE116640T1 (es)
AU (1) AU670582B2 (es)
CA (1) CA2131185C (es)
CZ (1) CZ285589B6 (es)
DE (1) DE69300043T2 (es)
DK (1) DK0560268T3 (es)
ES (1) ES2066623T3 (es)
FI (1) FI944217A0 (es)
GR (1) GR3015622T3 (es)
HU (2) HUT70617A (es)
IL (1) IL105035A (es)
NO (1) NO302570B1 (es)
NZ (1) NZ251267A (es)
OA (1) OA10092A (es)
PH (1) PH30734A (es)
PL (1) PL176362B1 (es)
RU (1) RU2140911C1 (es)
SK (1) SK280161B6 (es)
WO (1) WO1993018003A1 (es)
ZA (1) ZA931776B (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69333270T2 (de) 1992-03-11 2004-08-05 Narhex Ltd. Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
RU2126794C1 (ru) 1992-03-11 1999-02-27 Нархекс Лимитед Аминопроизводные оксо- или гидроксизамещенных гидразинов, способ их получения и фармацевтические композиции для ингибирования ретровирусной протеазы
US5888992A (en) 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US6071895A (en) 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
ES2123065T3 (es) 1992-08-25 1999-01-01 Searle & Co Hidroxietilamino-sulfonamidas utiles como inhibidores de proteasas retroviricas.
US5846993A (en) * 1992-12-22 1998-12-08 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
EP0610745A3 (en) * 1993-02-09 1994-09-28 Miles Inc Novel aminomethylene derivatives as immunosuppressants.
IL110898A0 (en) * 1993-09-10 1994-11-28 Narhex Australia Pty Ltd Polar-substituted hydrocarbons
US5527829A (en) * 1994-05-23 1996-06-18 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
CA2137406C (en) * 1994-12-06 2005-09-13 Pierre Louis Beaulieu Process for key intermediates for hiv protease inhibitors
US6037157A (en) 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
US5914332A (en) 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
US5883252A (en) * 1996-01-26 1999-03-16 Vertex Pharmaceuticals Incorporated Aspartyl protease inhibitors
US5705647A (en) * 1996-09-05 1998-01-06 Agouron Pharmaceuticals, Inc. Intermediates for making HIV-protease inhibitors
US5925759A (en) 1996-09-05 1999-07-20 Agouron Pharmaceuticals, Inc. Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
US5962725A (en) 1996-09-05 1999-10-05 Agouron Pharmaceuticals, Inc. Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir
US6232333B1 (en) 1996-11-21 2001-05-15 Abbott Laboratories Pharmaceutical composition
US6001851A (en) * 1997-03-13 1999-12-14 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US6084107A (en) * 1997-09-05 2000-07-04 Agouron Pharmaceuticals, Inc. Intermediates for making HIV-protease inhibitors
US6251906B1 (en) 1998-05-15 2001-06-26 Abbott Laboratories Retroviral protease inhibiting compounds
DE60038899D1 (de) 2000-01-19 2008-06-26 Abbott Lab Hiv-proteasehemmern
JP2003528071A (ja) * 2000-03-23 2003-09-24 エラン ファーマスーティカルズ インコーポレイテッド アルツハイマー病治療用組成物および方法
US6992081B2 (en) 2000-03-23 2006-01-31 Elan Pharmaceuticals, Inc. Compounds to treat Alzheimer's disease
PE20020276A1 (es) 2000-06-30 2002-04-06 Elan Pharm Inc COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
US6846813B2 (en) * 2000-06-30 2005-01-25 Pharmacia & Upjohn Company Compounds to treat alzheimer's disease
EP1666452A2 (en) 2000-06-30 2006-06-07 Elan Pharmaceuticals, Inc. Compounds to treat Alzheimer's disease
US20030096864A1 (en) * 2000-06-30 2003-05-22 Fang Lawrence Y. Compounds to treat alzheimer's disease
CN1217920C (zh) 2000-06-30 2005-09-07 艾兰制药公司 治疗早老性痴呆的化合物
CA2452039A1 (en) * 2001-06-27 2003-01-09 Elan Pharmaceuticals, Inc. Beta-hydroxyamine derivatives useful in treatment of alzheimer's disease
US20070213407A1 (en) * 2001-06-29 2007-09-13 Elan Pharmaceuticals And Pharmacia & Upjohn Company Llc Compounds to treat Alzheimer's disease
AU2003242405A1 (en) 2003-05-22 2004-12-13 Lead Chemical Co., Ltd. Compounds and preparaitons having antiviral effect
WO2005123669A1 (en) * 2004-06-10 2005-12-29 Board Of Trustees Of Michigan State University Synthesis of caprolactam from lysine
WO2007015805A1 (en) * 2005-07-20 2007-02-08 Eli Lilly And Company 1-amino linked compounds
BRPI0804506A2 (pt) * 2007-02-20 2011-08-30 Univ Michigan State processos para preparar caprolactama ou um derivado da mesma e ácido pipecolìnico, caprolactama ou um derivado da mesma, e, ácido pipecolìnico ou um derivado do mesmo
KR101518079B1 (ko) 2007-03-12 2015-05-06 넥타르 테라퓨틱스 올리고머-프로테아제 억제제 컨주게이트
US9095620B2 (en) 2008-03-12 2015-08-04 Nektar Therapeutics Reagents
US20110190488A1 (en) * 2008-07-24 2011-08-04 Wicks Douglas A Methods of Making Cyclic Amide Monomers and Related Derivatives
WO2010144869A2 (en) 2009-06-12 2010-12-16 Nektar Therapeutics Protease inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851387A (en) * 1986-10-14 1989-07-25 Banyu Pharmaceutical Co., Ltd. 5-substituted amino-4-hydroxy-pentanoic acid derivatives and their use
CA1340588C (en) * 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
GB8927913D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Amino acid derivatives
GB8927915D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Novel alcohols
MY110227A (en) * 1991-08-12 1998-03-31 Ciba Geigy Ag 1-acylpiperindine compounds.
ZA931777B (en) * 1992-03-13 1993-09-23 Bio Mega Boehringer Ingelheim Substituted pyrrolidine derivatives as HIV protease inhibitors.
IL110255A (en) * 1993-07-16 1998-12-06 Merck & Co Inc Creation and resolution of 2 tert-butylcarboxamidopiprazine
US5480887A (en) * 1994-02-02 1996-01-02 Eli Lilly And Company Protease inhibitors
GB2292146A (en) * 1994-08-11 1996-02-14 Merck & Co Inc HIV protease inhibitors useful for the treatment of AIDS

Also Published As

Publication number Publication date
WO1993018003A1 (en) 1993-09-16
DE69300043T2 (de) 1995-05-24
CZ285589B6 (cs) 1999-09-15
ZA931776B (en) 1993-09-24
PH30734A (en) 1997-10-17
ES2066623T3 (es) 1995-03-01
IL105035A (en) 1997-07-13
SK280161B6 (sk) 1999-09-10
OA10092A (en) 1996-12-18
JPH0673004A (ja) 1994-03-15
NO943383L (no) 1994-09-12
HU9402613D0 (en) 1994-11-28
ATE116640T1 (de) 1995-01-15
CA2131185C (en) 1997-05-27
GR3015622T3 (en) 1995-06-30
DE69300043D1 (de) 1995-02-16
RU2140911C1 (ru) 1999-11-10
NZ251267A (en) 1996-09-25
AU670582B2 (en) 1996-07-25
NO943383D0 (no) 1994-09-12
RU94040841A (ru) 1996-07-20
AP9300495A0 (en) 1993-04-30
AU3880893A (en) 1993-10-05
FI944217A (fi) 1994-09-13
KR950700253A (ko) 1995-01-16
HUT70617A (en) 1995-10-30
PL176362B1 (pl) 1999-05-31
CZ223294A3 (en) 1995-11-15
EP0560268B1 (en) 1995-01-04
HU211854A9 (en) 1995-12-28
FI944217A0 (fi) 1994-09-13
SK109094A3 (en) 1995-05-10
AP393A (en) 1995-08-07
JP3258422B2 (ja) 2002-02-18
DK0560268T3 (da) 1995-06-12
US5807870A (en) 1998-09-15
CA2131185A1 (en) 1993-09-16
IL105035A0 (en) 1993-07-08
EP0560268A1 (en) 1993-09-15

Similar Documents

Publication Publication Date Title
NO302570B1 (no) Substituerte pipekolinsyrederivater som HIV-protease-inhibitorer, farmasöytiske blandinger inneholdende dem og anvendelser av derivatene
NO304374B1 (no) 1-benzensulfonyl-1,3-dihydro-2H-benzimidazol-2-on-derivater, og farmas°ytiske blandinger som inneholder dem
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
DK0528734T3 (da) Thiaxolidin-2,4-dionderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
NO301824B1 (no) 1-benzensulfonyl-1,3-dihydro-indol-2-on-derivater og farmasöytiske blandinger som inneholder dem
NO303540B1 (no) Sulfonylalkanoylamino-hydroksyetylaminosulfonamider som er nyttige som retrovirale proteaseinhibitorer, farmas°ytiske preparater inneholdende forbindelsene samt anvendelse av forbindelsene for fremstilling av medikamenter
NO942994D0 (no) Aminoacetylmercaptoacetylamidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
NO302366B1 (no) 4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparat
DK0638317T3 (da) Farmaceutisk præparat, der indeholder glucosidase- og/eller amylasehæmmere og lipasehæmmer
DK0724570T3 (da) Amidinoderivater som NO syntase inhibitorer
DK0530087T3 (da) Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK1095020T3 (da) 2-Aminopyridinderivater, deres anvendelse som lægemidler og farmaceutiske præparater, der indeholder dem
DK0602028T3 (da) Aromatiske sulfonamidderivater, deres anvendelse som enzyminhibitorer og farmaceutiske præparater me d indhold deraf
DK0658585T3 (da) Amidinophenylalaninderivater, fremgangsmåde til deres fremstilling, deres anvendelse og midler indeholdende disse som antik
DK0632026T3 (da) Alfa-aminosyrederivater, en fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger, der indeholder dem
NO992998L (no) Nye analoger av camptotecin, anvendelse som medikamenter og farmasöytiske blandinger som inneholder disse
NO308004B1 (no) Nye aminofenylfosfonsyreforbindelser og farmasøytiske sammensetninger inneholdende dem
ES2095431T3 (es) N-(isoquinolein-5-il)-sulfonil-azacicloalcanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ITMI910846A1 (it) Derivati di flavoni, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
NO960812L (no) Alkoksysubstituerte ptoren
GR3023044T3 (en) Succinoylamino hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors.
DK0612763T3 (da) Cykliske angiopeptinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ITFI920134A1 (it) Derivati 7-neopentil xantinici, loro preparazione e composizioni farmaceutiche che li contengono
ES2091571T3 (es) Nuevos derivados peptidicos activos en los procesos de adhesion celular, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
IS4194A (is) Nýjar súbstitúeraðar 1-própenafleiður, lyfjablöndur sem innihalda þær og aðferðir við framleiðslu þeirra